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a b s t r a c t
There is a need by the European Commission (EC) regulations, as well as others, to reduce the use of
in vivo toxicity tests made on animals. Conventional in vitro tests were designed for non-nanoparticle
sized entities, and therefore do not necessarily assess the adverse impacts of engineered nanoparticles
(ENPs) on humans. Life cycle assessment (LCA) is a widely used methodology for evaluating the envi-
ronmental performance of products. Nevertheless, the application of LCA on ENPs is difﬁcult because the
characterization factors (CFs) of ENPs, as signiﬁcant input parameters in LCA, remain a major unknown.
It is a premise of this study to monitor the chemiluminescence (CL) spectra resulting from the reactive
oxygen species (ROS) trigger made from the presence of copper nanoparticles (CuNPs) to porcine neu-
trophils in vitro, thereby enabling to calculate the porcine and human toxicity CFs. The framework of a
scientiﬁc consensus model, USEtox model, is selected and the midpoint of CF is set as the inﬂammation
of pig or human. Finally, the present study recommends human and porcine inﬂammation CFs of CuNPs
in Europe to be 1.07 and 2.90 CTU (comparative toxic units) respectively.
1. Introduction
With the rapid development of newly engineered nanoparticles
(ENPs) [1–3], and their putative introduction to the environment,
there are serious safety concerns towards consumers and produc-
tion staff and therefore should be considered since the ENPs are
likely to enter the bloodstream of mammals via skin, inhalation
and ingestion [4–6]. Neutrophils are an abundant type of white
blood cell in mammals and are considered to be one of the earliest
and most prominent immune defense responders, acting through
variousmechanisms including phagocytosis, degranulation, etc [7].
OnceENPs invadeablood system,neutrophilswill ﬁnda role toplay
as an essential part of the innate immune system [8]. Many exper-
iments have been performed to investigate the mechanisms of
interactions between ENPs and human neutrophils [5,9–11]. How-
ever, to the best of our knowledge, using neutrophils to assess the
toxicity of ENPs has never been reported and is the premise of our
present study. In addition, when evaluating the potential impact
of ENPs-containing products (especially the under-design ones) to
humans, the experimentations fall short of expectationbeing either
insufﬁcient or impractical. Therefore, many assessment methods
for human toxicity have been developed to help relieve the pres-
sure of animal experimentation and provide the end-user with a
decision-making tool [12–14]. One such method is the life cycle
assessment (LCA) method that thrives to be an internationally
standardized tool and has been recommended by the European
Commission (EC) [15,16]. Characterization factors (CFs) are essen-
tial parameters for LCA and reﬂect the potential environmental
impacts and relative importance of materials [17]. Nevertheless,
there is a complete lack of human toxicity CFs towards various ENPs
[18].
The authors have selected copper nanoparticles (CuNPs) as the
representative ENPs, to in vitro investigate the chemiluminescence
of freshly isolated neutrophils from pigs. The pig is usually consid-
eredasanexcellent animalbiomedicalmodel forhuman,becauseof
the many similarities between human and pig [19,20]. The present
Fig. 1. (a) Mortality rates of neutrophils exposed to CuNPs of different concentrations over time (the conversion of unit g/mL to g/mln can be found in Supplementary Fig.
S1. For instance, 40g/mln corresponding to 200g/mL, 0.1g/mln corresponding to 0.5g/mL); (b) Neutrophil mortality induced by CuNPs after subtracting the control
(the horizontal error bars indicate the ranges of time needed for counting the neutrophils numbers); (c) Average mortality rate speed (AMRS) of neutrophils exposed to
CuNPs of different concentrations in ﬁve stages (divided by the red dash-dot line). Stage I from 0.878 to 2.925h, stage II from 2.925 to 5.025h, stage III from 5.025 to 7.175h,
stage IV from 7.175 to 9.025h and stage V from 9.025 to 11.025h. The x-axis values of the points in Fig. 1c are 1.9, 3.98, 6.1, 8.1 and 10.03h respectively. (For interpretation
of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
work has two purposes. The ﬁrst aim concerns the investigation
of the impact of CuNPs on life-status of porcine neutrophils while
observing their impact via chemiluminescent (CL) kinetic imprint-
ing and scanning electron microscopy (SEM) characterization. The
second aim uses the CL results to estimate porcine and human
inﬂammation CFs of CuNPs under the framework of a scientiﬁc
consensus model.
2. Materials and methods
2.1. Materials and instrumentation
Heparin sodium (H3393), histopaque (10771), dextran (D4876),
trypan (T8154), dimethyl sulfoxide (DMSO,D4540), glutaraldehyde
(G7651), copper NPs (CuNPs, <100nm, 634220) were purchased
from Sigma-Aldrich. Ethanol (02860) was provided by Fluka (Lyon,
France). Luminol/Enhancer (Bio-Rad HRP, CA) was used to amplify
chemiluminescence activity. Phosphate buffered saline (PBS buffer,
pH 7.4) was freshly prepared in our lab using sodium chloride
(S7653), sodium phosphate dibasic (94046) and sodium phosphate
monobasic (71505) purchased from Sigma (France). Zymosan A
(Z4250, sigma) suspension, used as a stimulating agent, in previous
prepared Krebs-Ringer phosphate (KRP) medium was opsonized
for 30min at 38 ◦C in a water bath (Grant Instruments Type VF,
Cambridge Ltd, UK) before being used.
Prior topreparing “a” stock analyte solution, an autoclave-steam
sterilizer (2540 ML-Tuttnauer, Netherlands) was used to sterilize
deionized water produced by Millipore water puriﬁcation system
(Molsheim, France). A conventional optical microscope was used
to count cells by a hemocytometer (Hausser scientiﬁc, Horsham,
USA). Different dilutions of nano copper solutions were well dis-
persed by an ultrasonic water bath (Elmasonic S30H) and a vortex
mixer (G560E, Scientiﬁc Industries Inc., USA). A centrifuge (Uni-
versal 320R, Andreas Hettich GmbH, Germany) was employed. The
morphology of cells was characterized by a ﬁeld emission scanning
electron microscopy (Hitachi SU8030, Japan) with an accelerating
voltage of 10kV.
2.2. Experimentation methodologies
The experiments in this study were ﬁrst based on a representa-
tive group of four pigs, and once similar tendencies were observed,
Fig. 2. (a) Calculated relative areas under CL spectra of neutrophils exposed to dif-
ferent concentrations of CuNPs for different durations; Error bars represent the
standard deviation based on three replicas in one experiments. (b)Maximumvalues
of calculated relative area under CL spectrums extracted from Fig. 2a. The size of the
circle represents the relative area value.
it was sufﬁcient to rely on experimental results from a single pig
with replicas made thrice. It should be noted, however, that the
calculation of characterization factors used the results from all four
pigs.
2.2.1. Neutrophilisolation
For each experiment, porcine blood was collected from the
external jugular vein of a clinically healthydomestic pig (≤6month,
100–110kg) in the morning between 4:30 to 5:10 in an slaughter
housenear Troyes (Sicaba, Pont-Sainte-Marie, France). The use of
pigs in this study was approved by the Service of Animal Health
Protection and Environment in the Prefecture of Aube (approval no.
10-387-901). In thedayof the experiment, 50mLporcinebloodwas
collected and anticoagulated with 7mg Heparin sodium dissolved
in 1mL KRPmedium. According to the gradient density centrifuga-
tionmethod as previously described [11,21,22], a slightly modiﬁed
isolation protocol of porcine neutrophils was used and described
in detail in the Supplementary material (Section S1).
2.2.2. Mortality rates calculation and chemiluminescence
measurement
The freshly isolated porcine neutrophils were exposed to
CuNPsat ten different concentrations in ten eppendorf tubes (1mL)
at 20 ◦C for about 11h.Here, a speciﬁc concentrationunitwas intro-
duced to better understand the relationship between CuNPs and
neutrophils: g/mln, which means the mass of CuNPs per million
neutrophils (The conversion method and an example were shown
in Supplementary Fig. S1). By subjecting the tube for a few sec-
onds of hand-shaking we assume that both neutrophils and CuNPs
were well dispersed. The 10 concentrations of CuNPs were 0, 0.1,
0.4, 1, 1.5, 2, 4, 10, 20, 40g/mln, respectively. During exposure,
the mortality rates of neutrophils were calculated at six selected
time points (0.875, 2.925, 5.025, 7.175, 9.025 and 11.025h) with
Trypan blue and Hemacytometer (Supplementary Fig. S2 illustrat-
ing the cell counting procedures). In addition, during the exposure,
chemiluminescence (CL) spectra were also recorded for each con-
centration over six selected periods of time (0.5, 2.5, 4.6, 6.8, 8.7
and 10.7h, respectively). CLmeasurementswere performedwithin
standard 96 wells Costar microtiter-plates (Corning, USA) and a
luminometer (Luminoskan Ascent, Thermo Fisher Scientiﬁc, USA).
The relative areas under each CL spectrum were respectively cal-
culated (an example of an original control CL spectrum is shown in
Supplementary Fig. S3).
2.2.3. Morphology characterization of CuNPs and neutrophils
Three different sample preparation procedureswere applied for
the surface morphology characterization of CuNPs. For apristine
sample, CuNPs powder without any treatment was spread onto
a carbon conductive tape; for CuNPs in water, 200g/mL CuNPs
solution with ddH2O was ultrasonicated for 5min, followed by
deposition of one drop of solution onto the gold-palladium cov-
ered glass substrate then dried for SEM imaging; furthermore, for
CuNPs inKRPbuffer solution, 200g/mLCuNPs inKRP solutionwas
ultrasonicated for 5min then followed the same procedures as for
neutrophils to prepare the SEM samples. The preparation of gold-
palladium covered glass substratewas described in Supplementary
material (Section S5).
The neutrophils exposed to selected concentrations of CuNPs
were all ﬁxed in 2.5wt% glutaraldehyde aqueous solutions
overnight after certain time intervals. Then, the neutrophil sus-
pensionwas centrifuged (4000 rpm, 5min), followed by a stepwise
dehydration using a series of graded ethanol aqueous solutions of
30%, 50%, 70%, 100% and 100% respectively. Each step was con-
ducted for 10min at room temperature followed by centrifugation
(4000 rpm, 5min). Hereafter, the neutrophils were well dispersed
in absolute ethanol, and deposited as 2.5–5L solution onto the
surface of prepared glass substrates. Prior to SEM characterization,
the samples were dried freely in the hood and covered with a thin
layer (2–3nm) of gold-palladium to suppress the charging effects.
2.3. Characterization factor
Life cycle impact assessment (LCIA) is one of the conventional
steps when conducting life cycle assessment (LCA), which could
translate the emissions into indicators that reﬂect the environment
and its health impacts [23]. The typical calculation in LCIA is based
on the following equation:
Ecosystemorhumanimpact =
∑
M×CF (1)
where CF is the substance-speciﬁc characterization factor that
expresses the potential impact of each single elementary material
ﬂow (M) contributing to the total impacts [24]. Characterization
factor (CF) thus facilitates the comparisons between the different
substances in terms of their ability of contribution to the impacts
on ecosystem or human.
2.3.1. Selection of characterization model
Manycharacterizationmethodsare available to calculate theCFs
for the human toxicity impact category, such as IMPACT2002+ [25],
ReCiPe [26], EDIP2003 [27], MEEuP [28], USEtox [29], etc. A com-
prehensive comparison between these models were performed by
Fig. 3. Scanning electron microscope (SEM) images of CuNPs: (a) Pristine CuNPs powders; (b) CuNPs in ddH2O; Cu nano-sheets originate from CuNPs in KRP buffer solution
with (c) 2500 magniﬁcation times and (c1) 50000 magniﬁcation times. The inset in c1 is a SEM image showing that the thickness of the nano-sheet is around 25nm.
Joint Research Centre of European Commission [16]. The compared
models were rated under the criteria deﬁned in ILCD Handbook:
LCIA – Framework and Requirements [30]. Several features make
the USEtox model stand out compared to others [16]. For example,
the USEtox model accounts for a chemical’s fate in the ecosys-
tem, human exposure and differences in toxicological response,
while the MEEup model is not [16]. In addition, the USEtox model
includes all vital model elements in a scientiﬁcally sound way for
most substances,whichmakes it have the best compliancewith the
science-based criteria [16]. Therefore, the USEtox has been recom-
mended as a scientiﬁc consensus method for the calculation of CFs
bymany international organizations suchas theEuropeanCommis-
sion (EC), Business Council for Sustainable Development (WBCSD),
etc [16,31,32]. In this study, the framework of the USEtox model
has been selected for calculating the porcine and human toxicity
CFs.
2.3.2. Model concept
In USEtox, a characterization factor (CF) describes a potential
impact on human health related to the emission of a given sub-
stance. It can be expressed by [29]:
CF = FF× XF× EF (2)
The human toxicity CF has a unit of comparative toxic units
(CTU), which represents the estimated increase in morbidity in
the total human population, per unit mass of a substance emit-
ted (cases/kgemission). The fate factor, FF (unit: day), represents the
residence time of a substance in a particular environment (such
as freshwater). The exposure factor, XF (unit: day−1), reﬂects the
rate at which a pollutant is able to transfer from a receiving com-
partment into the human population through a series of exposure
pathways. The EF is the human effect factor (unit: cases/kgintake)
and reﬂects the change in the life time disease probability, due to
the change in life time intake of a pollutant.
It should be highlighted that the chemiluminescence of exposed
porcine neutrophils provides the essential data for calculating the
effect factors (EFs) of CuNPs for both pigs and humans. The human-
equivalent toxicological data could be obtained by applying an
extrapolation factor for interspecies (pig to human) differences,
which makes it possible to use toxicological data on laboratory
animals to calculate the human toxicity CFs.
2.3.3. Fate factor and exposure factor calculation
The fate factor (FF) depends on the properties of the substances
and the interaction compartments (e.g. from urban air to fresh
water). Compared to materials in bulk phases, the ENPs show
different fate behaviors after entering the environment. Several
previously published studies proposed nano-speciﬁc fate mod-
els based on the colloidal science and the parameters of ENPs
[15,33–36]. Main differences between these models are the dif-
ferent compartments (air, water and soil) and removal processes
considered. A recently published model by our group took water
and sediment account and proposed a FF of 1.803day of CuNPs in
Europe freshwater for eco-toxicity assessment [37]. In terms of the
USEtoxmodel, the FFsof a substance inagivencompartment are the
same for ecotoxicity and human toxicity [32]. Thus, in this study,
the FF of 1.803day of CuNPs in European freshwater was applied to
calculate the characterization factors of CuNPs. The further details
about the fate model could be found in the related reference [37].
In this study, the exposure factor (XF) was set as 1 conserva-
tively due to the lack of bioaccumulation factors (BAF) of ENPs. The
experimental data are unavailable for BAF and the estimation of
BAF is also impracticable due to the invalid partition coefﬁcients
for ENPs [38]. Nevertheless, as one important factor in CF calcula-
tion, XFmay have a big inﬂuence on the ﬁnal CF values. Therefore,
further investigations of XF are necessary in the future.
Fig. 4. SEM images of: (a) fresh neutrophils after isolated 0.4h; neutrophils exposed to 40 ug/mln CuNPs for (b) 0.4h; (c) 1.1h; (d) 8h; (d1) and (d1′) with different
magniﬁcation times are SEM images zoomed in from (d).
2.3.4. Effect factor calculation
The EF (cases/kgintake) in this paper reﬂects the change of the
inﬂammation’s probability due to the change of the CuNPs intake
in the whole life time of either pig or human. Under the assump-
tion of linearity in dose-response (up towhere the life time disease
probability is 0.5), EF equals [29]:
EF =
0.5
ED50
(3)
ED50 (kg lifetime−1) is the dose amount of ingested substance
for either animal (ED50a, e.g. pig) or human (ED50h) during whole
its life time that causes an inﬂammation with a probability of 50%.
The ED50h of a human is calculated based on the following equation
[29]:
ED50h =
ED50a,t · BWh · LTh · N
AFa · AFt · 10
6
(4)
ED50a,t (mgkg−1 day−1) is the dose for animal during exposure
time t (day). AFa is the extrapolation factor for interspecies differ-
ences (pig to human is 1.1) [29], because the ED50h is derived from
the toxic data of pigs. BWh and LTh respectively represent aver-
age body weight (70kg, data from USEtox) and average lifetime of
human (70 years, data from USEtox). N is the number of days per
year (365days·year−1). Since chronic toxicity values have priority
in USEtox, thus an extrapolation factor AFt of 5 for acute to chronic
exposure is applied.
In this study, in order to compare the impacts of CuNPs on
human and pig, both porcine and human CFs were calculated. The
ED50a of pig can be calculated by:
ED50a =
ED50a,t · BWa · LTa · N
AFt · 10
6
(5)
where BWa represents average body weight (110kg, data from the
abattoir). The lifetimeofpig (LTa) is between10–20years [20]. Thus,
here, an average LTa value of 15 years is used.
In this study, it was assumed that there are no individual dif-
ferences among pigs or humans and when the amount of ROS
produced by neutrophils decreases to the 50% amount of ROS of
a control sample, the inﬂammation probability is 50%. Thereby, the
ED50a,t values were calculated based on the 50% calculated rela-
tive area under CL spectrum of the control samples. The detailed
calculation method of ED50a,t is described in Supplementary Fig.
S4.
3. Results and discussion
3.1. Effects of CuNPs on neutrophils: mortality rates
Fig. 1a shows that the exposure durations and concentrations of
CuNPshavebothpositive correlations on themortality rates of neu-
trophils. For instance, after exposure for about 11h, the mortality
rate of neutrophils with 40g/mln CuNPs was found to be 92.04%,
while that of no-CuNPs control neutrophils (unexposed cells to
CuNPs) was merely 34.63%. Fig. 1b displays the mortality induced
speciﬁcally by CuNPs by subtracting the mortality rates of the no-
CuNPs control neutrophils. Within about 3h, all the nine curves
showed obvious upward trends. After the initial increase, the mor-
tality rates induced by CuNPs remain steady, whichmeans that the
CuNPs may no longer inﬂuence the mortality of neutrophils after
an exposure of 3–7h. Fig. 1c shows the averagemortality rate speed
(AMRS) of neutrophils exposed to CuNPs. The detailed calculations
were described by equation S4 and S5 in Supplementary material.
In this study, the mortality rates of neutrophils were tested at six
time points (0.875, 2.925, 5.025, 7.175, 9.025 and 11.025h), which
divided thewhole test period intoﬁve stages (I, II, III, IV, V in Fig. 1c).
When the concentration of CuNPswas below0.1g/mln, the AMRS
of neutrophils is observed to increase at the onset (stage I and ﬁrst
half of stage II) then decreases (second half of stage II and stage III).
In contrast, when the concentration of CuNPs is above 0.4g/mln,
the AMRS of neutrophils continues a rapid decrease until 7 h (stage
I, II and III). Nevertheless, for all the neutrophils exposed to the
studied concentrations, the AMRS becomes stable in stage IV and
V.
3.2. Effects of CuNPs on neutrophils: chemiluminescence kinetics
Inﬂammatorymediators such as nanomaterials can trigger neu-
trophils to produce reactive oxygen species (ROS) [39]. Since the
intensity of light emitted by stimulated neutrophils is proportional
to the production of reactive oxygen species (ROS) [40,41], neu-
trophils’ capacity to generate ROS was indirectly estimated by
conducting chemiluminescence (CL) measurement. The relative
area under the CL spectrum represents the ability of neutrophils
to generate ROS and has been found to be useful for detection of
inﬂammatory diseases [41]. Fig. 2a shows the relative areas under
CL curves of neutrophils exposed to nine concentrations of CuNPs
at six selected time. All the curves in Fig. 2a have a trend of rise
initially then fall to 0 at different CuNPs concentrations (see insert
in Fig. 2a). It reveals that low concentrations of CuNPs could stimu-
late neutrophils, while high concentration CuNPs could inhibit the
oxidative burst of neutrophils.
Themortality ratesofneutrophilswith time∼50minare smaller
than with ∼3h (Fig. 1a). However, the amounts of ROS for 0.5h are
lower than for 2.5h when the concentration of CuNPs less than
5g/mln (Fig. 2a). It means that the lower concentration of CuNPs
(<5g/mln) stimulated neutrophils slower than higher ones.
Fig. 2b presents the maximum values of the calculated rela-
tive area under CL spectra at six selected time points. Each circle
indicates the given time point, at which concentration of CuNPs
stimulate the neutrophils most. In Fig. 2b, the maximum relative
area rises fast from 0.5 to 2.5h, then declines continuously. The
porcine neutrophils generate themost ROS at about 2.5h. Such cel-
lular behavior indicates that neutrophils would not be activated
immediately when exposed to CuNPs. Furthermore, when the neu-
trophils are fully activated, the concentrations of CuNPs that most
stimulate the neutrophils decrease along with time. We may infer
that the neutrophils become increasingly sensitive alongwith their
exposure to CuNPs.
3.3. Scanning electron microscope (SEM) characterization of
CuNPs
The surface morphology of CuNPs is shown in Fig. 3. It reveals
that the pristine CuNPs and theCuNPsdispersed in ddH2Oare gran-
ulated and around 50–200nm in diameter (Fig. 3a and b). After
being dispersed in a salt-based KRP buffer solution, these same
CuNPs were observed to form Cu nano-sheets (Fig. 3c and c1)
due to some unknown mechanism. The plan dimension of highly
anisotropic nanosheets can reach over 15m (Fig. 3c) while the
thickness is estimated around 25nm (Fig. 3c1 inset).
3.4. Rearrangement of copper nano-sheets initiated by porcine
neutrophils
Fig. 4 shows the morphology of neutrophils before and after
being exposed to 40g/mln CuNPs for different durations via
scanning electron microscope (SEM) imaging. Moreover, similar
characterization on neutrophils exposed to 20g/mln CuNPs was
also reported in Supplementary Fig. S4. The size of unexposed
porcine neutrophils is about 3m and the cells are rounded with
membrane folds, as similar as the results in previous reporting
[42,19]. It is obvious that CuNPs already changed to nano-sheets
at 0.4h incubation with neutrophils and the size of nano-sheets
is around 3–5m. The morphology of neutrophils changed after
exposure to 40g/mln CuNPs (Fig. 4b–d). After incubation with
CuNPs for 1.1h, the phagocytosis phenomenon of neutrophils was
observed as shown in Fig. 4c. Interestingly, the neutrophils were
surroundedby copper nano-sheet particles, at a considerably larger
size (Fig. 4d). The thickness of a single copper nano-sheet covering
the neutrophils, ranges from20 to 50nm (estimated from Fig. 4d1′)
similar to theoriginalnano-sheets inFig. 3c1.Nevertheless, theplan
dimension of nanosheets is about 2–5m, which is much smaller
than the nanosheets without neutrophils. In addition, it should be
noted that after neutrophils were exposed to 40g/mln CuNPs for
8h, the CL signal decreased to 0, despite the fact that there were
still about 10% live neutrophils (see Fig. 1a). Here two reasons are
proposed. On one hand, neutrophilsmay ‘exhaust’ themselves dur-
ing their interactions with the copper particles, thus reducing their
light signal output drastically, though they are observed to be alive;
on the other hand, the layers of copper nano-sheetsmay scatter and
quench some of the light produced by the CL reaction.
Moreover, it was found when the CuNPs concentration was
lower than 2g/mln, there was no coverage of copper nano-
sheets on neutrophils, while the coverage started to be observed
from 2g/mln CuNPs onwards (Supplementary Fig. S5). Thus, even
though the samepristine CuNPs (Fig. 3a)were used in all the exper-
iments, the morphology of CuNPs during the experiment became
complex, which may be inﬂuenced by the CuNPs concentrations
and exposure time with neutrophils.
3.5. Characterization factor calculation
The EFs for pig and human over time (values are listed in Sup-
plementary Table S1) were respectively calculated based on the
average values of ED50a,t whichwere derived from the chemilumi-
nescence results. Fig. 5 shows thehumanandporcine inﬂammation
CFs based on different exposure periods. To the best of our knowl-
edge, this is the ﬁrst time that the porcine toxicity CFs are reported.
To simplify the comparison, the porcine toxicity CF keeps the same
unit (CTU) ashuman toxicityCFbuthas a slightly differentmeaning.
The CF for porcine toxicity impact represents the potential increase
in morbidity in pigs per unit mass of a chemical emitted. Since the
human inﬂammation CFs are based on the same porcine toxicologi-
cal data, both human and porcine inﬂammation CFs display similar
upward trends over time. No matter in which exposure period, the
Fig. 5. Human and porcine inﬂammation CFs for different exposure periods. Error
bars represent the standard deviation based on four individual pigs. The CFs values
of 24h are derived from the exponential extension of the original toxic data (details
can be found in Supplementary Fig. S6).
inﬂammation’s cases of pig are 2.7 times higher than that of human.
Except the employed extrapolation factor for interspecies differ-
ences (pig to human: 1.1), the different body weight and life-time
between human and pig are also reasons causing the CFs variation
between human and pig. The body weight of pig is about 1.6 times
heavier than human, while the lifespan of pig is∼4.7 times shorter
than human.
The CFs values for 24h and 8h are respectively about 3000 and
20 times of CFs values for 2h. It indicates that exposure time is
a signiﬁcant parameter when calculating CFs. Here, we give the
recommendations for using CFs values of 8h in the future life
cycle assessment (LCA) of CuNPs containing products, because the
human neutrophils are considered short-lived cells with a half-life
in the circulation of approximately 8h in humans [43]. Therefore,
the recommended human and porcine inﬂammation CFs are 1.07
and 2.90 CTU respectively. Nevertheless, it should be noted that the
recruitment of neutrophils is not considered, which may overesti-
mate the CFs values.
4. Conclusion
In summary, a rapid and promising method to evaluate the
impacts of cooper nanoparticles on pig and human via a combi-
nation of in vitro experiments and assessment model is reported.
The results by further toxicity evaluation with USEtox model were
considered representative, despite the fact that some assumptions
and simpliﬁcations were made in the calculation of CFs. In the case
of CuNPs, it was found that both the exposure time and concentra-
tions of CuNPs have a positive correlation on neutrophil mortality
rates. The CL kinetic results indicated that the neutrophils exposed
2.5h to CuNPs showed the highest activity ability. In addition,
an estimated rearrangement of copper nano-sheets initiated by
porcine neutrophils was also presented. Furthermore, a porcine
and human inﬂammation characterization factor of 1.07 and 2.90
CTU for CuNPs was recommended respectively. These CF values for
CuNPs could be used in the future for assessing the risks of CuNPs
containing products by LCA method.
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